<p>8 week old male C57BL/6 mice (<i>n</i> = 4/condition) were placed on MCDD or chow diet for 4 weeks. (<b>A</b>) IL-17A and IL-17F production was determined in cells following the gating on: CD45<sup>+</sup>, TCRβ<sup>+</sup>, NK1.1<sup>-</sup>, CD4<sup>+</sup> or CD8<sup>+</sup>. (<b>B</b>) Percent of hepatic immune cells (CD45<sup>+</sup>) producing IL-17A. (<b>C</b>) Percent of hepatic immune cells (CD45<sup>+</sup>) producing IL-17F. (<b>D</b>) Percent of hepatic TCRβ<sup>+</sup> cells (CD4<sup>+</sup> or CD8<sup>+</sup> T cells) producing IL-17A. (<b>E</b>) Percent of hepatic TCRβ<sup>+</sup> cells (CD4<sup>+</sup> or CD8<sup>+</sup> T cells) producing IL-17F. (<b>F</b>) Mean fluorescent intensity of IL-17A in TCRβ<sup>+</sup> cells (...
This review mainly elaborates on the animal models available for understanding the pathogenesis of t...
This review mainly elaborates on the animal models available for understanding the pathogenesis of t...
Nonalchoholic fatty liver disease (NAFLD) is a problem of increasing prevalence and clinical signifi...
<p>8 week old male IL-17RA<sup>-/-</sup>, IL-17A<sup>-/-</sup>, and IL-17F<sup>-/-</sup> mice on a C...
Inflammation plays a central pathogenic role in the pernicious metabolic and end-organ sequelae of o...
Inflammation plays a central pathogenic role in the pernicious metabolic and end-organ sequelae of o...
Nonalcoholic fatty liver disease (NAFLD) is an emerging worldwide health concern. The disease may in...
Nonalcoholic fatty liver disease (NAFLD) is an emerging worldwide health concern. The disease may in...
<p>(A) Gr-1 staining and quantitation of Gr1-positive cells in WT and CD18 mut liver at 3 wk. Photom...
The mechanisms responsible for the evolution of steatosis toward non-alcoholic steato-hepatitis (NAS...
The mechanisms responsible for the evolution of steatosis toward non-alcoholic steato-hepatitis (NAS...
<p>(<b>A</b>) Serum IL-17 levels in male C57BL/6 mice at indicated time post PolyI:C stimulation. (<...
<p>. (A) Experimental protocol: Mice were i.v. injected with ConA weekly for up to four weeks to est...
WT or Il23r-/- mice were fed a ND or WD for 20 weeks, followed by terminal analyses (A). FACS quanti...
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is a common, chronic liver disease wor...
This review mainly elaborates on the animal models available for understanding the pathogenesis of t...
This review mainly elaborates on the animal models available for understanding the pathogenesis of t...
Nonalchoholic fatty liver disease (NAFLD) is a problem of increasing prevalence and clinical signifi...
<p>8 week old male IL-17RA<sup>-/-</sup>, IL-17A<sup>-/-</sup>, and IL-17F<sup>-/-</sup> mice on a C...
Inflammation plays a central pathogenic role in the pernicious metabolic and end-organ sequelae of o...
Inflammation plays a central pathogenic role in the pernicious metabolic and end-organ sequelae of o...
Nonalcoholic fatty liver disease (NAFLD) is an emerging worldwide health concern. The disease may in...
Nonalcoholic fatty liver disease (NAFLD) is an emerging worldwide health concern. The disease may in...
<p>(A) Gr-1 staining and quantitation of Gr1-positive cells in WT and CD18 mut liver at 3 wk. Photom...
The mechanisms responsible for the evolution of steatosis toward non-alcoholic steato-hepatitis (NAS...
The mechanisms responsible for the evolution of steatosis toward non-alcoholic steato-hepatitis (NAS...
<p>(<b>A</b>) Serum IL-17 levels in male C57BL/6 mice at indicated time post PolyI:C stimulation. (<...
<p>. (A) Experimental protocol: Mice were i.v. injected with ConA weekly for up to four weeks to est...
WT or Il23r-/- mice were fed a ND or WD for 20 weeks, followed by terminal analyses (A). FACS quanti...
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is a common, chronic liver disease wor...
This review mainly elaborates on the animal models available for understanding the pathogenesis of t...
This review mainly elaborates on the animal models available for understanding the pathogenesis of t...
Nonalchoholic fatty liver disease (NAFLD) is a problem of increasing prevalence and clinical signifi...